An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects, scientists reported on Wednesday.
Less than a month into Obamacare's second open-enrollment season, the HHS says "we're off to a solid start."
Hedge fund mogul Bill Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan.
Pfizer’s $110 billion bid for AstraZeneca was one of the biggest business stories of 2014 – so could a new bid be one of the biggest stories in 2015?
Get the best of CNBC in your inbox